103 - Designing and implementing clinical trials that inform clinical practice

Speaker(s)

• 

  Nick Daneman, MD, MSc

  Associate Professor
  University of Toronto
  Toronto, ON, Canada

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• 

  Angela Huttner, MD

  Attending physician
  Geneva University Hospitals

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• 

  Mical Paul, MD

  Director, Infectious Diseases Institute
  Rambam Health Care Campus
  Haifa, HaZafon, Israel

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.25 hours of MOC Credit
ACPE Credits: ACPE 1.25 Knowledge-based contact hours of pharmacy CE
ACPE Number: 0221-9999-20-487-H04-P

Learning Objectives:

• recognize the potential of pragmatic clinical trials to impact practice
• summarize key considerations in designing investigator-initiated trials
• discuss challenges associated with implementation of investigator-initiated trials

Presentations:

• 4:15pm – 5:30pm EDT

  Clinical Trials to Inform Antimicrobial Stewardship
  Nick Daneman, MD, MSc – University of Toronto
• 4:15pm – 5:30pm EDT

  Investigator-initiated Clinical Trials for MDR Gram-negative Pathogens
  Mical Paul, MD – Rambam Health Care Campus
• 4:15pm – 5:30pm EDT

  Patient-focused Approaches to Phase 3 Studies
  Angela Huttner, MD – Geneva University Hospitals